31 August 2020

Polyphor AG has entered into an equity-linked financing arrangement with the French company IRIS to raise a gross amount of up to CHF 19.3 million over a period of two years.
Under the financing instrument, IRIS will receive Polyphor shares to be created from the company’s conditional capital based on an interest-free mandatory convertible bonds program.
VISCHER acted as legal advisor to Polyphor. The team included Matthias Staehelin, Angelo Imperiale and Sebastian Flückiger (all Corporate) as well as Nadia Tarolli and Adrian Briner (both Tax).

Categories: Banking & Finance, Life Sciences, Pharma, Biotech

You are currently offline. Some pages or content may fail to load.